MDL-105519 is a potent and selective antagonist at the glycine recognition site of the NMDA receptor; it exhibits anticonvulsant activity in genetically based, chemically induced, and electrically mediated seizure models; demonstrates anxiolytic effects in the rat separation-induced vocalization model; and shows muscle-relaxant activity at lower doses.